文献速递血液净化与透析

透析间期体重增长:国际透析预后与实践模式研究(DOPPS)中的趋势、预测因素及相关结局

Interdialytic Weight Gain: Trends, Predictors, and Associated Outcomes in the International Dialysis Outcomes and Practice Patterns Study (DOPPS).
PubMed 文献 · Am J Kidney Dis · 2016-11-17

基于DOPPS 2至5期(2002-2014年)21,919例透析龄≥1年的血液透析患者,分析透析间期体重增长(IDWG)的时间与地区趋势、预测因素及与临床结局的关联。结果显示美国、加拿大、欧洲IDWG下降,透析液钠浓度每升高1 mEq/L与相对IDWG增加0.13(95%CI 0.11-0.16)相关;相对IDWG≥5.7%与死亡率升高相关(校正HR 1.23,95%CI 1.08-1.40),≥4%与液体超负荷住院风险升高相关。

要点

  • 2002至2014年美国、加拿大、欧洲IDWG下降,日本与澳新下降幅度较小。
  • 透析液钠浓度每升高1 mEq/L,相对IDWG增加0.13(95%CI 0.11-0.16)。
  • 相对IDWG≥5.7%与死亡率升高相关(校正HR 1.23,95%CI 1.08-1.40)。

核心结论

  • 过去十年IDWG下降部分由透析液钠浓度降低解释。
  • 聚焦降低高IDWG发生的质量改进策略可能改善血液透析患者结局。

研究设计与样本

  • 分析1:序贯横断面分析设施和患者层面IDWG预测因素及其时间趋势。
  • 分析2:前瞻性队列研究评估IDWG与死亡和住院风险的关联。
  • 研究对象为DOPPS 2至5期(2002-2014年)21,919例透析龄≥1年的血液透析患者。

主要发现

  • 从2期至5期,IDWG在美国下降0.29 kg(透析后体重的0.5%)、加拿大下降0.25 kg(0.8%)、欧洲下降0.22 kg(0.5%),日本与澳大利亚/新西兰下降更小。
  • 可改变因素中最显著的是设施平均透析液钠浓度:每升高1 mEq/L,相对IDWG增加0.13(95%CI 0.11-0.16)。
  • 与相对IDWG 2.5%-3.99%相比,相对IDWG≥5.7%者死亡率升高(校正HR 1.23,95%CI 1.08-1.40)。
  • 与相对IDWG 2.5%-3.99%相比,相对IDWG 4%-5.69%和≥5.7%者液体超负荷住院风险升高(HR分别为1.28 [95%CI 1.09-1.49]和1.64 [95%CI 1.27-2.13])。

临床怎么用

  • 原文结论未据此给出具体推荐。

局限性

  • 可能存在残余混杂。
  • 无膳食盐摄入数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: High interdialytic weight gain (IDWG) is associated with adverse outcomes in hemodialysis (HD) patients. We identified temporal and regional trends in IDWG, predictors of IDWG, and associations of IDWG with clinical outcomes. STUDY DESIGN: Analysis 1: sequential cross-sections to identify facility- and patient-level predictors of IDWG and their temporal trends. Analysis 2: prospective cohort study to assess associations between IDWG and mortality and hospitalization risk. SETTING & PARTICIPANTS: 21,919 participants on HD therapy for 1 year or longer in the Dialysis Outcomes and Practice Patterns Study (DOPPS) phases 2 to 5 (2002-2014). PREDICTORS: Analysis 1: study phase, patient demographics and comorbid conditions, HD facility practices. Analysis 2: relative IDWG, expressed as percentage of post-HD weight (<0%, 0%-0.99%, 1%-2.49%, 2.5%-3.99% [reference], 4%-5.69%, and ≥5.7%). OUTCOMES: Analysis 1: relative IDWG as a continuous variable using linear mixed models; analysis 2: mortality; all-cause and cause-specific hospitalization using Cox regression, adjusting for potential confounders. RESULTS: From phase 2 to 5, IDWG declined in the United States (-0.29kg; -0.5% of post-HD weight), Canada (-0.25kg; -0.8%), and Europe (-0.22kg; -0.5%), with more modest declines in Japan and Australia/New Zealand. Among modifiable factors associated with IDWG, the most notable was facility mean dialysate sodium concentration: every 1-mEq/L greater dialysate sodium concentration was associated with 0.13 (95% CI, 0.11-0.16) greater relative IDWG. Compared to relative IDWG of 2.5% to 3.99%, there was elevated risk for mortality with relative IDWG≥5.7% (adjusted HR, 1.23; 95% CI, 1.08-1.40) and elevated risk for fluid-overload hospitalization with relative IDWG≥4% (HRs of 1.28 [95% CI, 1.09-1.49] and 1.64 [95% CI, 1.27-2.13] for relative IDWGs of 4%-5.69% and ≥5.7%, respectively). LIMITATIONS: Possible residual confounding. No dietary salt intake data. CONCLUSIONS: Reductions in IDWG during the past decade were partially explained by reductions in dialysate sodium concentration. Focusing quality improvement strategies on reducing occurrences of high IDWG may improve outcomes in HD patients.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Wong MM, McCullough KP, Bieber BA, et al. Interdialytic Weight Gain: Trends, Predictors, and Associated Outcomes in the International Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2016. PMID: 27866963. doi:10.1053/j.ajkd.2016.08.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。